YKL-40 Protein Levels and Clinical Outcome of Human Endometrial Cancer

Author： Peng C   Peng J   Jiang L   You Q   Zheng J   Ning X  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.38, Iss.4, 2010-07, pp. : 1448-1457

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The significance of YKL-40 protein in liver fibrosis

By Tao Hui   Yang Jing-Jing   Shi Kai-Hu   Huang Cheng   Zhang Lei   Lv Xiong-Wen   Li Jun  

Inflammation Research, Vol. 63, Iss. 4, 2014-04 ,pp. : 249-254

Springer Publishing Company

Access to resources Recommend Favorite

Is YKL-40 a new therapeutic target in cancer?

By Johansen Julia S   Jensen Benny Vittrup   Roslind Anne   Price Paul A  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 2, 2007-02 ,pp. : 219-234

Informa Healthcare

Access to resources Recommend Favorite

Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma

By  

Cancer, Vol. 120, Iss. 24, 2014-12 ,pp. : 3972-3980

Blackwell Publishing

Access to resources Recommend Favorite

YKL-40: a Potential Biomarker for Osteoarthritis

By Huang K   Wu LD  

The Journal of International Medical Research, Vol. 37, Iss. 1, 2009-01 ,pp. : 18-24

Field House Publishing

Access to resources Recommend Favorite

Expression of Monocyte Chemotactic Protein-1 in Human Endometrial Cancer Cells and the Effect of Treatment with Tamoxifen or Buserelin

By Wang L   Zheng W   Zhang S   Chen X   Hornung D  

The Journal of International Medical Research, Vol. 34, Iss. 3, 2006-05 ,pp. : 284-290

Field House Publishing

Access to resources Recommend Favorite